title: [Investigation on the molecular mechanisms of anti-hepatocarcinoma herbs of traditional Chinese medicine by cell cycle microarray].
abstract: OBJECTIVE
  To design DNA microarray and investigate the molecular anti-tumor mechanism of herbs of traditional Chinese medicine.
  
  
  METHODS
  cDNA microarrays consisting of 56 probes representing 24 human cell cycle genes were constructed, Four anti-hepatocarcinoma herbs including Radix Linderae, Hebra Artemisiae Annuae, Radix Amebiae, Radix Astragli, were chosen. Effects of herbs on SMMC-7721 cell cycle were observed by flow cytometry assay. Effects of herbs on cell cycle gene expression in SMMC-7721 cells were analyzed by comparing hybridization of Dig-Labeled cDNAs from herb-treated cells and cDNAs from untreated cells.
  
  
  RESULTS
  Expressions of cell cycle geneswere changed in different degrees after herbs treated. Some genes were down-regulated and some genes were up-regulated. The changes in gene expression agreed with the results of flow cytometry assay.
  
  
  CONCLUSIONS
  The results suggest that these herbs may have effects on cell cycle and DNA damage checkpoint genes which may be the mechanism of the herbs, and DNA microarray can be used to investigate the biological function of extracts of traditional Chinese medicine.
authors.affiliation: Molecular Cytogenetics Lab, Nankai University, Tianjin 300071, China.
authors.forename: Guang-Liang
authors.initials: GL
authors.lastname: Wang
authors.forename: Cheng-Bin
authors.initials: CB
authors.lastname: Chen
authors.forename: Jian-Ming
authors.initials: JM
authors.lastname: Gao
authors.forename: Hong
authors.initials: H
authors.lastname: Ni
authors.forename: Tong-Shun
authors.initials: TS
authors.lastname: Wang
authors.forename: Li
authors.initials: L
authors.lastname: Chen
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000302:isolation & purification / Q000494:pharmacology*; D019306:Artemisia / Q000737:chemistry; D027885:Astragalus propinquus / Q000737:chemistry; D006528:Carcinoma, Hepatocellular / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor; D051358:Cyclin-Dependent Kinase 4; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics / Q000378:metabolism; D018844:Cyclin-Dependent Kinases / Q000235:genetics / Q000378:metabolism; D004365:Drugs, Chinese Herbal / Q000302:isolation & purification / Q000494:pharmacology*; D005784:Gene Amplification; D020869:Gene Expression Profiling; D018816:Genes, cdc / Q000187:drug effects; D006801:Humans; D027443:Lindera / Q000737:chemistry; D029684:Lithospermum / Q000737:chemistry; D008113:Liver Neoplasms / Q000378:metabolism / Q000473:pathology*; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D010946:Plants, Medicinal / Q000737:chemistry; D018809:Proliferating Cell Nuclear Antigen / Q000235:genetics / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000378:metabolism; D020687:cdc25 Phosphatases / Q000235:genetics / Q000378:metabolism
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D019941:Cyclin-Dependent Kinase Inhibitor p16; D004365:Drugs, Chinese Herbal; D018809:Proliferating Cell Nuclear Antigen; D011518:Proto-Oncogene Proteins; C495900:CDK4 protein, human; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases; C517004:CDC25A protein, human; D020687:cdc25 Phosphatases